Drug Shortage Report for TEVA-BROMAZEPAM

Last updated on 2020-02-07 History
Report ID 103552
Drug Identification Number 02230584
Brand name TEVA-BROMAZEPAM
Common or Proper name BROMAZEPAM 3MG TAB
Company Name TEVA CANADA LIMITED
Active Ingredient(s) BROMAZEPAM
Strength(s) 3MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15
Estimated end date 2020-02-29
Actual end date 2020-02-06
Shortage status Resolved
Updated date 2020-02-07
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-02-07 French Compare
v7 2020-02-07 English Compare
v6 2020-01-30 French Compare
v5 2020-01-30 English Compare
v4 2020-01-24 French Compare
v3 2020-01-24 English Compare
v2 2020-01-17 French Compare
v1 2020-01-17 English Compare